EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Detection Rate and Spectrum of Pathogenic Variations in a Cohort of 83 Patients with Suspected Hereditary Risk of Kidney Cancer

Zangbéwendé Guy Ouedraogo iD, Florian Ceruti, Mathis Lepage iD, Mathilde Gay-Bellile, Nancy Uhrhammer iD, Flora Ponelle-Chachuat iD, Yannick Bidet iD, Maud Privat, Mathias Cavaillé iD

Genes · 2023

DOI: 10.3390/genes14111991 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2023. Verfasst von Zangbéwendé Guy Ouedraogo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Département d'Oncogénétique, Centre Jean Perrin, 63011 Clermont-Ferrand, France. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Centre Jean Perrin, Clermont-Ferrand, France.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hereditary predisposition to cancer affects about 3–5% of renal cancers. Testing criteria have been proposed in France for genetic testing of non-syndromic renal cancer. Our study explores the detection rates associated with our testing criteria. Using a comprehensive gene panel including 8 genes related to renal cancer and 50 genes related to hereditary predisposition to other cancers, we evaluated the detection rate of pathogenic variants in a cohort of 83 patients with suspected renal cancer predisposition. The detection rate was 7.2% for the renal cancer genes, which was 2.41-fold higher than the estimated 3% proportion of unselected kidney cases with inherited risk. Pathogenic variants in renal cancer genes were observed in 44.5% of syndromic cases, and in 2.7% of non-syndromic cases. Incidental findings were observed in CHEK2, MSH2, MUTYH and WRN. CHEK2 was associated with renal cancer (OR at 7.14; 95% CI 1.74–29.6; p < 0.003) in our study in comparison to the gnomAD control population. The detection rate in renal cancer genes was low in non-syndromic cases. Additional causal mechanisms are probably involved, and further research is required to find them. A study of the management of renal cancer risk for CHEK2 pathogenic variant carriers is needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsHumansGerm-Line MutationGenetic TestingGenetic Predisposition to Disease

Stichwörter der Autor:innen

CHEK2cohortdetection ratehereditary cancerrenal cancer

Autor:innen und Institutionen

  • Département d'Oncogénétique, Centre Jean Perrin, 63011 Clermont-Ferrand, France.
  • Service de Biochimie et Génétique Moléculaire, CHU Clermont-Ferrand, 63000 Clermont-Ferrand, France.
  • Université Clermont Auvergne, CNRS, Inserm, iGReD, 63001 Clermont-Ferrand, France.
  • Service d'Urologie, CHU Gabriel Montpied, 63000 Clermont-Ferrand, France.
  • Université Clermont Auvergne, INSERM, U1240 Imagerie Moléculaire et Stratégies Théranostiques, 63000 Clermont-Ferrand, France.

ORCID-Profile: Zangbéwendé Guy Ouedraogo, Mathis Lepage, Nancy Uhrhammer, Flora Ponelle-Chachuat, Yannick Bidet, Mathias Cavaillé

Förderung

  • Centre Jean Perrin, Clermont-Ferrand, France

Zitieren

APA

Ouedraogo, Z. G., Ceruti, F., Lepage, M., Gay-Bellile, M., Uhrhammer, N., Ponelle-Chachuat, F., Bidet, Y., Privat, M., & Cavaillé, M. (2023). Detection Rate and Spectrum of Pathogenic Variations in a Cohort of 83 Patients with Suspected Hereditary Risk of Kidney Cancer. Genes. https://doi.org/10.3390/genes14111991

Vancouver

Ouedraogo ZG, Ceruti F, Lepage M, Gay-Bellile M, Uhrhammer N, Ponelle-Chachuat F, et al. Detection Rate and Spectrum of Pathogenic Variations in a Cohort of 83 Patients with Suspected Hereditary Risk of Kidney Cancer. Genes. 2023. doi:10.3390/genes14111991

BibTeX
@article{Ouedraogo2023,
  author = {Ouedraogo, Zangbéwendé Guy and Ceruti, Florian and Lepage, Mathis and Gay-Bellile, Mathilde and Uhrhammer, Nancy and Ponelle-Chachuat, Flora and Bidet, Yannick and Privat, Maud and Cavaillé, Mathias},
  title = {Detection Rate and Spectrum of Pathogenic Variations in a Cohort of 83 Patients with Suspected Hereditary Risk of Kidney Cancer},
  journal = {Genes},
  year = {2023},
  doi = {10.3390/genes14111991}
}
Kostenlos starten →